Skip to search formSkip to main contentSkip to account menu

CP 99219

Known as: CP 99,219, CP-99,219, CP-99219 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

trovafloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates.
Trovafloxacin (CP-99,219) was very active against Gram-negative species examined including Haemophilus influenzae, Moraxella… 
1997
1997
Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin
A single-dose study was conducted to determine concentrations of trovafloxacin (CP-99,219) achieved in the cerebrospinal fluid… 
Highly Cited
1996
Highly Cited
1996
Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro
The MICs of trovafloxacin, ciprofloxacin, ofloxacin, and sparfloxacin at which 90% of isolates are inhibited for 55 isolates of… 
Highly Cited
1996
Highly Cited
1996
Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219)
A single 200-mg oral dose of trovafloxacin (CP-99,219) was given to each of eight healthy male volunteers, and the concentrations… 
1996
1996
Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys
The pharmacokinetics of trovafloxacin [CP-99,219; 7-(3-azabicyclo[3.1.0]hexyl)-naphthyridone] were studied in rats, dogs, and… 
1995
1995
Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
Trovafloxacin (CP-99,219) is a new fluoroquinolone antibacterial agent with a broad spectrum of activity against Gram-positive… 
Highly Cited
1995
Highly Cited
1995
Pharmacokinetics and safety of trovafloxacin (CP-99, 219), a new quinolone antibiotic, following adminstration of single oral doses to healthy male volunteers
Trovafloxacin (CP-99,219) is a new fluoroquinolone antibacterial agent with a broad spectrum of activity against Gram-positive… 
1995
1995
Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis
CP-99,219 is a new fluoroquinolone that has excellent activity against gram-positive organisms including penicillin- and… 
Highly Cited
1994
Highly Cited
1994
In vitro activity of the new fluoroquinolone CP-99,219
The in vitro activity of the new fluoroquinolone CP-99,219 [7-(3-azabicyclo[3.1.0]hexyl)naphthyridone] was compared with those of… 
1994
1994
In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)